280
Participants
Start Date
September 30, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Pneumococcal protein vaccine
One dose of 50 µg of each of three proteins with adjuvant (aluminium hydroxide) IM
Pneumococcal protein vaccine
Three doses, 4 weeks apart, of 10 µg of each of three proteins with adjuvant (aluminium hydroxide) IM
Pneumococcal protein vaccine
Three doses, 4 weeks apart, of 25 µg of each of three proteins with adjuvant (aluminium hydroxide) IM
Pneumococcal protein vaccine
Three doses, 4 weeks apart, of 25 µg of each of three proteins without adjuvant IM
Pneumococcal protein vaccine
Three doses, 4 weeks apart, of 50 µg of each of three proteins with adjuvant (aluminium hydroxide) IM
ICDDR,B, Dhaka
Sanofi Pasteur, a Sanofi Company
INDUSTRY
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER